Skip to main content
. Author manuscript; available in PMC: 2021 Aug 15.
Published in final edited form as: Cancer Res. 2020 Dec 4;81(4):898–909. doi: 10.1158/0008-5472.CAN-20-0790

Figure 3. MDM2-MDMX heterodimerization facilitates MDM2-p53 binding.

Figure 3.

(A) MEFs of indicated genotypes were treated with 4-OHT for 2 hours. The cells were then harvested, lysed, and immunoprecipitated (IP) for MDM2 and MDMX, and blotted with the indicated proteins. Input represents 5% of total cell lysate utilized for IP. (B) MEFs of indicated genotypes were treated and blotted as in A. (C) MEFs of indicated genotypes were treated and blotted as in A.